US Stock MarketDetailed Quotes

AMPH Amphastar Pharmaceuticals

Watchlist
  • 49.335
  • +3.245+7.04%
Trading Nov 8 14:46 ET
2.37BMarket Cap16.39P/E (TTM)

Amphastar Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amphastar Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
194.69M
191.21M
-3.48M
Miss Est.
+7.83%
+5.90%
-1.79%
EPS
1.01
0.78
-0.23
Miss Est.
--
-14.29%
-22.57%
Analyst Rating
Strong Buy

Nov 8, 2024

Amphastar Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 189.800M --
-- 2024/Q4 -- / 194.110M --
Nov 6, 2024 2024/Q3 191.214M / 194.693M --
Aug 7, 2024 2024/Q2 182.394M / 170.910M --
May 8, 2024 2024/Q1 171.800M / 174.713M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 189.800M--
--2024/Q4-- / 194.110M--
Nov 6, 20242024/Q3191.214M / 194.693M--
Aug 7, 20242024/Q2182.394M / 170.910M--
May 8, 20242024/Q1171.800M / 174.713M--

Unlock Free Earnings Estimates

Amphastar Pharmaceuticals Earnings Reports

  • Amphastar Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 8 05:29

  • Amphastar Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 10 04:20

  • Amphastar Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 11 03:05

  • Amphastar Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 1 11:45

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 8, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Cannabis & Hemp
    Cannabis & Hemp
    Intraday-1.07%